Han, S., Ronzitti, G., Arnson, B., Leborgne, C., Li, S., Mingozzi, F., & Koeberl, D. (2019). Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance Induction. Mol Ther Methods Clin Dev.
Chicago-stil citatHan, Sang-oh, Giuseppe Ronzitti, Benjamin Arnson, Christian Leborgne, Songtao Li, Federico Mingozzi, och Dwight Koeberl. "Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT Via Immune Tolerance Induction." Mol Ther Methods Clin Dev 2019.
MLA-referensHan, Sang-oh, et al. "Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT Via Immune Tolerance Induction." Mol Ther Methods Clin Dev 2019.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.